Up next

Autoplay

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

23 Views • 07/30/23
Share
Embed
administrator
administrator
Subscribers
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay